Skip to main content

Genetic screening and allied services: structure, process and objective

  • Chapter
Medico-Social Management of Inherited Metabolic Disease

Abstract

Service programmes formulated under the discipline of medical genetics are designed to reduce the burden of genetic disease among individuals in the community. In this discussion we define, in general terms, the amount and nature of genetic disease in man; then in detail the structures which appear best to serve the processes of patient intake through genetic screening or medical referral; and the processes of diagnosis, counselling and treatment which follow in the application of knowledge to patients with genetic disease.1 We conclude with comments on an existing programme, the Quebec Network of Genetic Medicine, which articulates all of these principles; their application at the national level is occurring through the accreditation of genetic centres under the newly established Canadian College of Medical Genetics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Clow, C. L., Fräser, F. C., Laberge, C. and Scriver, C. R. (1973). On the application of knowledge to the patient with genetic disease. In A. C. Steinberg and A. G. Beam (eds.), Progress in Medical Genetics, Vol. 9, p. 159. ( New York: Grune and Stratton )

    Google Scholar 

  2. McKusick, V. A. (1975). Catalogs of autosomal dominant, autosomal recessive and X-linked phenotypes. Mendelian Inheritance in Man, 4th ed. ( Baltimore: Johns Hopkins Press )

    Google Scholar 

  3. Carr, D. M. (1971). Genetic basis of abortion. Ann. Rev. Genet. 5, 65

    Google Scholar 

  4. Poland, J. B. and Lowry, R. B. (1974). The use of spontaneous abortuses and still births in genetic counselling. Am. J. Obstet Gynecol., 118, 322

    PubMed  CAS  Google Scholar 

  5. Trimble, B. K. and Doughty, J. H. (1974). The amount of hereditary disease in human population. Ann. Hum. Genet. ( London ), 38, 199

    Article  PubMed  CAS  Google Scholar 

  6. World Health Organization. (1972). Genetic Disorders: Prevention, Treatment and Rehabilitation, ( Geneva: WHO Tech. Rep. Ser. No. 497 )

    Google Scholar 

  7. Childs, B., Miller, S. M. and Bearn, A. G. (1972). Gene mutation as a cause of human disease. In H. E. Sutton and M. I. Harris (eds.), Mutagenic Effects of Environmental Contamination, p. 3. ( New York: Academic Press )

    Google Scholar 

  8. Scriver, C. R., Neal, J. L., Saginur, R. and Clow, A. (1973). The frequency of genetic disease and congenital malformation among patients in a pediatric hospital. Can. Med. Ass. J., 108, 1111

    PubMed  CAS  Google Scholar 

  9. Day, N. and Holmes, L. B. (1973). The incidence of genetic disease in a University Hospital population. Am. J. Hum. Genet., 25, 237

    PubMed  CAS  Google Scholar 

  10. Reich, E., Wallace, S., Ben-Yishay, M., Schlesinger, S., Marks, J. and Bloom, A. D. Genetic Disease in a Pediatric Hospital. (In press)

    Google Scholar 

  11. Carter, C. O. (1956). Changing patterns in the causes of death at the Hospital for Sick Children. Great Ormond Street J., No. 11, 65

    Google Scholar 

  12. Roberts, D. F., Chavez, J. and Court, S. D. M. (1970). The genetic component in child mortality. Arch. Dis. Child., 45, 33

    Article  PubMed  CAS  Google Scholar 

  13. Motulsky, A. G. and Boman, H. (1974). Genetics and atherosclerosis. In G. Scheuer (e. g., Proc. 3rd Int. Symposium on Atherosclerosis, Oct. 1973 ( Berlin: Springer-Verlag )

    Google Scholar 

  14. Dumond, D. E. (1975). The limitation of human population: a natural history. Science, 187, 713

    Article  PubMed  CAS  Google Scholar 

  15. Scriver, C. R. (1972). Screening and treatment of hereditary (metabolic) disease. In Human Genetics Symposium, Proc. IV International, Cong. Human Genetics, p. 10. ( Paris: Excerpta Medica Found )

    Google Scholar 

  16. Westwood, A. and Ralne, D. N. (1973). Some problems of heterozygote recognition in inherited metabolic disease with special reference to phenylketonuria. In J. W. T. Seakins, R. A. Saunders and C. Toothill (eds.), Treatment of Inborn Errors of Metabolism. SSIEM Sympos. No. 10, p. 63. ( London: Churchill Livingstone )

    Google Scholar 

  17. Murphy, E. A. and Chase, G. A. (1975). Principles of genetic counseling. ( Chicago; Year Book Medical Pub. )

    Google Scholar 

  18. Harris, H. (1968). Molecular basis of hereditary disease. Br. Med. J., ii, 135

    Google Scholar 

  19. Harris, H. and Hopkinson, D. A. (1972). Average heterozygosity per locus in man: an estimate based on the incidence of enzyme polymorphism. Ann. Hum. Genet., 36, 9

    Article  PubMed  CAS  Google Scholar 

  20. Goldstein, J. L., Hazzard, W. R., Schrott, H. G., Bierman, E. L. and Motulsky, A. G. (1973). Hyperlipidaemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J. Clin. Invest,. 52, 1533

    Article  PubMed  CAS  Google Scholar 

  21. Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L. and Motulsky, A. G. (1973). Hyperlipidaemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hvperlipidemia. J. Clin. Invest., 52, 1544

    Article  PubMed  CAS  Google Scholar 

  22. Hazzard, W. R., Goldstein, J. L., Schrott, H. G., Motulsky, A. G. and Bierman, E. L. (1973). Hyperlipidaemia in coronary heart disease. III. Evaluation of lipoprotein phenotypes in 156 genetically defined survivors of myocardial infarction. J. Clin. Invest., 52, 1569

    Article  PubMed  CAS  Google Scholar 

  23. Levy, R. I., Morganroth, J. and Rifkin, B. M. (1974). Drug therapy. Treatment of hvperlipidemia. N. Engl. J. Med., 290, 1295

    Article  PubMed  CAS  Google Scholar 

  24. National Academy of Sciences. (1975). Genetic Screening. Programs, Principles and Research. Washington, D. C.

    Google Scholar 

  25. North, A. F. Jr. (1975). Personal communication

    Google Scholar 

  26. Wilson, J. M. G. and Jungner, G. (1968). Principles and Practice of Screening for Disease. ( Geneva: WHO Public Health Papers No. 34 )

    Google Scholar 

  27. Whitby, L. G. (1974). Screening for disease. Definitions and criteria. Lancet, ii, 819

    Google Scholar 

  28. Sackett, D. L. and Holland, W. W. (1975). Controversy in the detection of disease. Lancet, ii, 357

    Google Scholar 

  29. Scriver, C. R. (1965). Screening newborns for hereditary metabolic disease. Pediatr. Clin. North Am., 12, 807

    PubMed  CAS  Google Scholar 

  30. World Health Organization. (1967). Standardization of Procedures for the study of Glucose-6-phosphate Dehydrogenase. ( Geneva: WHO Tech. Rep. Ser. 366 )

    Google Scholar 

  31. World Health Organization. (1968). Screening for Inborn Errors of Metabolism, ( Geneva,: WHO Tech. Rep. Ser. 401 )

    Google Scholar 

  32. Hecht, F. and Lovrien, E. W. (1970). Genetic diagnosis in the newborn. A part of preventive medicine. Pediatr. Clin. North Am., 17, 1039

    PubMed  CAS  Google Scholar 

  33. World Health Organization. (1966). Haemoglobinopathies and Allied Disorders. ( Geneva: WHO Tech. Rep. Ser. 338 )

    Google Scholar 

  34. Gold, R. J. M., Maag, U. R., Neal, J. L. and Scriver, C. R. (1974). The use of biochemical data in screening for mutant alleles and in genetic counseling. Ann. Hum. Genet., 37, 315

    Article  PubMed  CAS  Google Scholar 

  35. Kirkman, H. N. (1972). Enzyme defects. In A. G. Steinberg and A. G. Beam (eds.), Progress in Medical Genetics, Vol. 8, p. 125. ( New York: Grune and Stratton )

    Google Scholar 

  36. Guthrie, R. and Susi, A. (1963). A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics., 32, 338

    PubMed  CAS  Google Scholar 

  37. McCaman, M. W. and Robins, E. (1962). Fluorimetric method for the determination of phenylalanine in serum. J. Lab. Clin. Med., 59, 885

    CAS  Google Scholar 

  38. Hill, J. B., Summer, G. K., Pender, M. W. and Roszel, N. O. (1965). An automated procedure for blood phenylalanine. Clin. Chem., 11, 541

    PubMed  CAS  Google Scholar 

  39. Murphy, E. A. and Mutalik, G. S. (1969). The application of Bayesian methods in genetic counseling. Hum. Her ed., 19, 126

    Article  Google Scholar 

  40. Rosenblatt, D. and Scriver, C. R. (1968). Heterogeneity in genetic control of phenylalanine metabolism in man. Nature (London), 218, 677

    Article  CAS  Google Scholar 

  41. Delvin, E., Pottier, A., Scriver, C. R. and Gold, R. J. M. (1974). The application of an automated hexosaminidase assay to genetic screening. Clin. Chim. Acta, 53, 135

    Article  PubMed  CAS  Google Scholar 

  42. Starfield, B. and Holtzman, N. A. (1975). A comparison of effectiveness of screening for phenylketonuria in the United States, United Kingdom and Ireland. N. Engl. J. Med., 293, 118

    Article  PubMed  CAS  Google Scholar 

  43. Childs, B. and der Kaloustian, M. (1968). Genetic heterogeneity. N. Engl. J. Med., 279, 1205 and 1267

    Google Scholar 

  44. McKusick, V. A. (1971). The nosology of genetic disease. Hosp. Prac., 6, 93

    Google Scholar 

  45. Bartholome, K. (1974). A new molecular defect in phenylketonuria. Lancet, 11, 1580

    Article  Google Scholar 

  46. Smith, I., Clayton, B. E. and Wolff, O. H. (1975). New variant of phenyl-ketonuria with progressive neurological illness unresponsive to phenylalanine restriction. Lancet, i, 1108

    Google Scholar 

  47. Kaufman, S., Holtzman, N. A., Milstien, S., Butler, I. J. and Krumholz, A. (1975). Phenylketonuria due to deficiency of dihydropteridine reductase. N. Engl. J. Med. 293, 785

    Article  PubMed  CAS  Google Scholar 

  48. Murphy, E. A. (1968). The rationale of genetic counseling. J. Pediatrics, 72, 121

    Article  CAS  Google Scholar 

  49. Fraser, F. C. (1971). Genetic counseling. Hosp. Pract6, 49

    Google Scholar 

  50. Leonard, C. O., Chase, G. A. and Childs, B. (1972). Genetic counseling: A consumer’s view. N. Engl. J. Med., 287, 433

    Article  PubMed  CAS  Google Scholar 

  51. Kaback, M. M., Becker, M. H. and Ruth, M. V. (1974). Sociologie studies in human genetics. 1. Compliance factors in a voluntary heterozygote screening program. Birth Defects Orig. Article Series. (Natl Foundation), Vol. X, No. 6, p. 163.

    Google Scholar 

  52. Beck, E., Blaichman, S., Scriver, C. R. and Clow, C. L. (1974). Advocacy and compliance in genetic screening. Behaviour of physicians and clients in a voluntary Tay-Sachs testing program. N. Engl. J. Med., 291, 1166

    Article  PubMed  CAS  Google Scholar 

  53. Clow, C., Reade, T. and Scriver, C. R. (1971). Management of hereditary metabolic disease. The role of allied health personnel. N. Engl. J. Med., 284, 1292

    Article  PubMed  CAS  Google Scholar 

  54. Raine, D. N. (1974). Screening for disease: Inherited metabolic disease. Lancet, ii, 996

    Article  Google Scholar 

  55. Grenier, A. and Laberge, C. (1974). Depistage des maladies metaboliques hereditaires au Quebec. Union Med. Can., 103, 453

    PubMed  CAS  Google Scholar 

  56. Clow, C. L., Scriver, C. R. and Davies, E. (1969). Results of mass screening for hyperaminoacidemias in the newborn infant. Am. J. Dis. Child., 117, 48

    PubMed  CAS  Google Scholar 

  57. Laberge, C. (1969). Hereditary tyrosinemia in a French Canadian isolate. Am. J. Hum. Genet. 21, 36

    Google Scholar 

  58. Goldman, H. (1972). The repository for mutant human cell strains. In L. Dallaire (ed.), Med. Res. Council (Can.) Prenatal Diagnosis Newsletter, Vol. 1, No. 2, p. 6

    Google Scholar 

  59. Dussault, J. H., Coulombe, P., Laberge, C., Letarte, J., Guyda, H. and Khoury K. (1975). Preliminary report on a mass screening program for neonatal hypothyroidism. J. Pediatr., 86, 670

    Article  PubMed  CAS  Google Scholar 

  60. Clow, C. L., Ishmael, H., Scriver, C. R., Murray, K., Campeau, H., Long, D. and Steinberg, H. A. (1975). The national food distribution centre for management of patients with hereditary metabolic disease. Bull. Genet. Soc. Can., 6, 29

    Google Scholar 

  61. Miller, J. R. (1975). Canadian College of Medical Genetics. Can. Med. Ass. J., II3, 357

    Google Scholar 

  62. Holtzman, N. A., Meek, A. G. and Mellits, E. D. (1974). Neonatal screening for phenylketonuria. IV. Factors influencing the occurrence of false positives. Am. J. Pub. Health, 64, 775

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1977 The Society for the Study of Inborn Errors of Metabolism

About this chapter

Cite this chapter

Scriver, C.R., Laberge, C., Clow, C.L. (1977). Genetic screening and allied services: structure, process and objective. In: Raine, D.N. (eds) Medico-Social Management of Inherited Metabolic Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6173-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-6173-2_2

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-011-6175-6

  • Online ISBN: 978-94-011-6173-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics